Representative before the EPO

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

We have observed 35 EP applications Daniel Joseph Wise has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 5, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11799567

TISSUE ENGINEERED BLOOD VESSELS

IPC classification:
A61L 27/18, A61L 27/36, A61L 27/38, A61L 27/50
Applicant:
Cordis Corporation
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Thomas Prock, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12186995

Differentiation of human embryonic stem cells

IPC classification:
C12N 5/071
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12723731

ANTI-NERVE GROWTH FACTOR ANTIBODIES AND METHODS OF PREPARING AND USING THE SAME

IPC classification:
C07K 16/22, C07K 16/46
Applicant:
NVIP Pty Ltd
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Agent:
Anne Marie Carr, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP12723730

ANTI-NERVE GROWTH FACTOR ANTIBODIES AND METHODS OF PREPARING AND USING THE SAME

IPC classification:
C07K 16/22, C07K 16/46
Applicant:
NVIP Pty Ltd
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Agent:
Anne Marie Carr, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP12723732

ANTI-NERVE GROWTH FACTOR ANTIBODIES AND METHODS OF PREPARING AND USING THE SAME

IPC classification:
C07K 16/22, C07K 16/46
Applicant:
NVIP Pty Ltd
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Agent:
Anne Marie Carr, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP13163291

Treatment of pluripotent cells

IPC classification:
C12N 5/0735
Applicant:
Janssen Biotech, Inc.
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12831075

METHODS OF DETECTING SEPSIS

IPC classification:
C40B 30/04, C40B 40/08
Applicant:
Cepheid Inc
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13155730

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

IPC classification:
C12N 5/07, C12N 5/071
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12775538

BACTERIUM FOR USE AS A PROBIOTIC FOR NUTRITIONAL AND MEDICAL APPLICATIONS

IPC classification:
A61K 35/74, A61P 1/00, A61P 37/00
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13185690

Vaccines including antigen from four strains of influenza virus

IPC classification:
A61K 39/145, A61P 31/16
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12797981

ADJUVANTED INFLUENZA B VIRUS VACCINES FOR PEDIATRIC PRIMING

IPC classification:
A61K 39/145, A61P 31/16
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12855593

USE OF GROWTH HORMONE FRAGMENTS

IPC classification:
A61K 38/18, A61P 19/02, A61P 19/04, A61P 21/06
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Agent:
Ann De Clercq, De Clercq & Partners cvba
Status:
GRANT OF PATENT INTENDED
EP12777815

AN ASSAY OF CELL MEDIATED IMMUNE RESPONSIVENESS

IPC classification:
G01N 33/50
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP13754321

PAIN TREATMENT

IPC classification:
A61K 48/00, A61P 25/04, C12N 15/00, C12N 15/113, C12N 15/63
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Agent:
Martin Grund, Grund Intellectual Property Group
Status:
GRANT OF PATENT INTENDED
EP13758233

NOVEL TRIAZINE DERIVATIVE

IPC classification:
A61K 31/53, A61K 31/5377, A61P 19/00, A61P 29/00, A61P 35/00, A61P 35/02, A61P 37/06, A61P 43/00, C07D 251/42
Agent:
Wolf E. Sajda, Meissner Bolte & Partnerschaft mbB
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12804281

A CELL MEDIATED IMMUNE RESPONSE ASSAY WITH ENHANCED SENSITIVITY

IPC classification:
G01N 33/50
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13718488

METHODS OF DETECTING BLADDER CANCER

IPC classification:
C12Q 1/68
Applicant:
Cepheid Inc
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP14183359

Cell-derived viral vaccines with low levels of residual cell dna

IPC classification:
A61K 39/12, A61K 39/145
Applicant:
Novartis Vaccines and Diagnostics GmbH
Applicant:
Novartis Influenza Vaccines Marburg GmbH
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13726225

IMPROVED SAFETY TESTING

IPC classification:
A61K 39/12, C12Q 1/68
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION WITHDRAWN
EP14187466

Artificial antigen presenting cell for preparing CD8 cell suspension for use in the treatment of cancer

IPC classification:
A61K 35/14, A61K 39/00, A61K 39/39, C12N 5/0784
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP11776962

THREADS OF CROSS-LINKED HYALURONIC ACID AND METHODS OF PREPARATION AND USE THEREOF

IPC classification:
A61L 15/28, A61L 27/20, A61L 31/04, C08B 37/00
Applicant:
Allergan Holdings France S.A.S.
Agent:
Hoffmann Eitle PartmbB
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP15154014

Influenza vaccination

IPC classification:
A61K 39/155, A61K 48/00
Applicant:
Novartis Vaccines and Diagnostics Inc.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14705575

INFLUENZA VIRUS REASSORTMENT

IPC classification:
A61K 39/00, A61K 39/145, C07K 14/11, C12N 15/85
Applicant:
Novartis AG
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14743871

KV1.3 ANTAGONISTS AND METHODS OF USE

IPC classification:
A61K 48/00, C12P 19/34
Applicant:
Janssen Biotech, Inc.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14722402

PALM ACTIVATED DRUG DELIVERY DEVICE

IPC classification:
A61M 5/168, A61M 5/20, A61M 5/315, A61M 5/32, A61M 5/42, A61M 5/48, A61M 5/50
Applicant:
Janssen Biotech, Inc.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP14768743

INTERFERON ALPHA AND OMEGA ANTIBODY ANTAGONISTS

IPC classification:
C07K 16/24
Applicant:
Janssen Biotech, Inc.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14717823

ROSEBURIA FLAGELLIN AND IMMUNE MODULATION

IPC classification:
A61K 38/16, A61K 39/02, A61K 48/00, A61P 1/00, A61P 17/00, A61P 19/00, A61P 29/00, A61P 37/00, A23L 5/00
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP13171200

Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents

IPC classification:
A61K 31/165, A61K 31/7088, A61K 45/06, A61K 48/00, C12N 15/113, C12Q 1/68, G01N 33/483, G01N 33/50, G01N 33/574
Agent:
Andrea Gisela Lasar, Maiwald Patentanwalts GmbH
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP11767067

SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES

IPC classification:
A61B 17/00, A61B 17/20, A61K 9/14, A61K 39/00, A61K 39/145, A61M 37/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12704581

NAPHTHYRIDINE DERIVATIVES AS INHIBITORS OF HYPOXIA INDUCIBLE FACTOR

IPC classification:
A61K 31/4375, A61P 9/10, C07D 471/04
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11835635

HBV TREATMENT

IPC classification:
A61K 31/713, C12N 15/113
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Agent:
Martin Grund, Grund Intellectual Property Group
Status:
PATENT GRANTED
EP15724442

USE OF SMALL MOLECULES TO ENHANCE MAFA EXPRESSION IN PANCREATIC ENDOCRINE CELLS

IPC classification:
C12N 5/071
Applicant:
Janssen Biotech, Inc.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16804857

COMPOSITIONS COMPRISING BACTERIAL STRAINS

IPC classification:
A61K 35/74, A61K 39/08, A61P 11/06, A61P 19/00, A61P 27/02, A61P 29/00
Applicant:
4D Pharma Research Ltd.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
Examination is in progress
EP15892802

PRODUCTION OF METAL-ORGANIC FRAMEWORKS

IPC classification:
B01J 19/24, B81B 1/00, C07F 19/00
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16736952

CYS80 CONJUGATED IMMUNOGLOBULINS

IPC classification:
A61K 47/48, A61K 49/00, C07K 16/28, C07K 16/30
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Daniel Joseph Wise, Carpmaels & Ransford LLP
Status:
Request for examination was made

Please Sign in to use this feature